drugset / Trial / NCT06720714
A Study to Assess the Concentration of Rozanolixizumab in the Breast Milk of Healthy Lactating Women
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to assess the concentration of rozanolixizumab in mature breast milk of healthy study participants following administration of a single dose of rozanolixizumab
Timeline
- Start
- 2024-12-03
- Primary completion
- 2025-05-12
- Completion
- 2025-05-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rozanolixizumab | Monoclonal antibody | — | Subcutaneous |
Indications
No indication recorded.